We are live on ! Find out more
USNA icon

Usana Health Sciences

197 hedge funds and large institutions have $1.62B invested in Usana Health Sciences in 2018 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 64 increasing their positions, 72 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 21

10% more capital invested

Capital invested by funds: $1.48B → $1.62B (+$141M)

4% more funds holding

Funds holding: 189197 (+8)

2.32% more ownership

Funds ownership: 52.99%55.31% (+2.3%)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

11% less repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 72

26% less call options, than puts

Call options by funds: $1.05M | Put options by funds: $1.41M

Holders
197
Holders Change
+8
Holders Change %
+4.23%
% of All Funds
4.49%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
30
Increased
64
Reduced
72
Closed
21
Calls
$1.05M
Puts
$1.41M
Net Calls
-$362K
Net Calls Change
+$378K

USNA Hedge Fund Activity: Q3 2018 in Review

197 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q3 2018, worth a combined $1.62B — up 9.5% from $1.48B a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new USNA positions and 21 closed out — a net gain of 9 holders — while 64 added to existing stakes and 72 trimmed.

The largest buyer was AJO LP, adding an estimated $42.7M. The largest seller was Nordea Investment Management, cutting an estimated $27.4M.

  • 197 institutional investors held Usana Health Sciences (USNA) as of Q3 2018, up from 189 in Q2 2018.
  • Funds reported $1.62B of Usana Health Sciences stock for Q3 2018, up 9.5% quarter-over-quarter.
  • 30 funds opened new Usana Health Sciences positions in Q3 2018 and 21 closed out, a net change of +9 holders.
  • The largest Usana Health Sciences buyer in Q3 2018 was AJO LP, an estimated $42.7M added.
  • The largest Usana Health Sciences seller in Q3 2018 was Nordea Investment Management, an estimated $27.4M sold.

Based on aggregated 13F filings for Q3 2018.